SCHEMBL3148401

SCHEMBL3148401

FC(F)(F)Oc1cccc(OCC2CO2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.75
TP53 P04637 3/20 0.75
TSHR P16473 3/20 0.75
HIF1A Q16665 2/20 0.75
CYP3A4 P08684 1/20 0.75
SMN1; SMN2 Q16637 1/20 0.75
TDP1 Q9NUW8 1/20 0.57
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 2/20 0.46
CYP1A2 P05177 1/20 0.46
PPARG P37231 1/20 0.46
DRD4 P21917 2/20 0.45
ATM Q13315 1/20 0.44
PKM P14618 2/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
GLA P06280 1/20 0.41
FGFR1 P11362 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37802 0.87 ALDH1A1 (1.00) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL31537008 0.87 ALDH1A1 (1.00) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL12289601 0.87 ALDH1A1 (1.00) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL13806572 0.87 ALDH1A1 (1.00) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL31537002 0.87 ALDH1A1 (1.00) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7968648 0.83 ALDH1A1 (0.60) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7968652 0.83 ALDH1A1 (0.60) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL1227958 0.83 ALDH1A1 (0.60) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL19813823 0.82 ALDH1A1 (0.89) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL7196302 0.82 ALDH1A1 (0.89) ALDH1A1TP53TSHRHIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137193-B1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI SA (FR) 2017-08-09 EP disclosed
US-8642603-B2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI (FR) 2014-02-04 US disclosed
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2010-03-25 US disclosed
EP-2137193-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF Sanofi-Aventis (FR) 2009-12-30 EP disclosed
WO-2008112483-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF GRM2, GRM1, GRIN2C ALDH1A1 1875/4885TP53 4885/4885TSHR 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.